Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.

@article{Reinhardt2006DiagnosticPO,
  title={Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients.},
  author={Michael J. Reinhardt and Alexius Young Joe and U. J{\"a}ger and Andrea Huber and Alexander B. Matthies and Jan Bucerius and Roland R{\"o}del and Holger Strunk and Thomas Bieber and Hans-J{\"u}rgen Biersack and Thomas T{\"u}ting},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2006},
  volume={24 7},
  pages={1178-87}
}
PURPOSE To assess the diagnostic performance of positron emission tomography/computed tomography (PET/CT) using (18)F-fluorodeoxyglucose (FDG) for N- and M-staging of cutaneous melanoma. PATIENTS AND METHODS This is a retrospective and blinded study of 250 consecutive patients (105 women, 145 men; age 58 +/- 16 years) who underwent FDG-PET/CT for staging of cutaneous melanoma at different time points in the course of disease. Whole-body FDG-PET/CT was performed 101 +/- 21 minutes… CONTINUE READING

Citations

Publications citing this paper.

Similar Papers

Loading similar papers…